Veradermics, Inc
MANE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827635
In the last 90 days, Veradermics, Inc insiders filed 0 open-market purchases and 4 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $4.17B in total; superinvestors Viking Global Investors and Maverick Capital hold it.
Holders of 5% or more of MANE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Veradermics, Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Longitude Capital Partners V, LLC | 13D/A | 11.30%4.65M shares | −1.20 ppfrom 12.50% | Feb 12, 20262 filings | May 5, 2026 | SEC |
| Suvretta Capital Management, LLC | 13D/A | 8.80%3.72M shares | −1.10 ppfrom 9.90% | Feb 11, 20263 filings | Aug 21, 2026 | SEC |
| FMR LLC | 13G | 7.60%3.19M shares | New | Aug 6, 20261 filing | Aug 6, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
12 Schedule 13D and 13G filings on Veradermics, Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 20266:32 PM ET | Suvretta Capital Management, LLCand 3 others | 13D/A | 8.80%3.72M shares | −1.10 ppfrom 9.90% | Aug 19, 2026 | SEC |
| Aug 14, 20268:00 PM ET | Sr One Capital Management, LLCand 5 others | 13D/A | 4.90%2.08M shares | −1.50 ppfrom 6.40%Below 5% | Aug 12, 2026 | SEC |
| Aug 6, 202610:43 AM ET | FMR LLCand 1 other | 13G | 7.60%3.19M shares | New | Jun 30, 2026 | SEC |
| May 15, 20265:48 PM ET | Viking Global Investors LPand 9 othersSuperinvestorViking Global Investors | 13G/A | 4.50%1.69M shares | −1.30 ppfrom 5.80%Below 5% | Mar 31, 2026 | SEC |
| May 7, 20264:41 PM ET | Citadel Advisors LLCand 6 others | 13G | 4.50%1.87M shares | NewBelow 5% | Apr 30, 2026 | SEC |
| May 5, 20269:39 PM ET | Suvretta Capital Management, LLCand 3 others | 13D/A | 9.90%4.17M shares | −2.00 ppfrom 11.90% | May 1, 2026 | SEC |
| May 5, 20269:07 PM ET | Longitude Capital Partners V, LLCand 5 others | 13D/A | 11.30%4.65M shares | −1.20 ppfrom 12.50% | May 1, 2026 | SEC |
| May 5, 20267:44 PM ET | Seven Fleet Capital Management LPand 3 others | 13D | 0.20%80.0K shares | NewBelow 5% | May 1, 2026 | SEC |
| Feb 12, 20266:11 PM ET | Longitude Capital Partners V, LLCand 5 others | 13D | 12.50%4.65M shares | New | Feb 5, 2026 | SEC |
| Feb 12, 20264:54 PM ET | Viking Global Investors LPand 10 othersSuperinvestorViking Global Investors | 13G | 5.80%2.15M shares | New | Feb 5, 2026 | SEC |
| Feb 11, 20265:22 PM ET | Suvretta Capital Management, LLCand 3 others | 13D | 11.90%4.17M shares | New | Feb 5, 2026 | SEC |
| Feb 11, 20264:29 PM ET | Sr One Capital Management, LLCand 5 others | 13D | 6.40%2.40M shares | New | Feb 5, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Veradermics, Inc shares.
No Form 144 notices for Veradermics, Inc are on file.